NSC |
Compound |
Enrichment |
Correlation |
NSC 113497 |
16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) |
0.0352383000003056 |
0.06080731 |
NSC 135880 |
Null |
0.0352383000003056 |
0.25186378 |
NSC 163424 |
4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- |
0.0352383000003056 |
0.12339608 |
NSC 23925 |
Null |
0.0352383000003056 |
0.1462032 |
NSC 275647 |
5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- |
0.0352383000003056 |
0.073717788 |
NSC 294961 |
5-Bromo-3-(2-oxo-2-phenylethylidene)- 1,3-dihydroindol-2-one |
0.0352383000003056 |
0.18886525 |
NSC 339137 |
PHYSALOLACTONE |
0.0352383000003056 |
0.19821476 |
NSC 354974 |
Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- |
0.0352383000003056 |
-0.073381062 |
NSC 371777 |
Null |
0.0352383000003056 |
0.14606565 |
NSC 372155 |
2-Propenamide, N-[(cyanoamino)iminomethyl]-2-methyl- |
0.0352383000003056 |
0.14611212 |